Following are published, science-based articles regarding inflammatory breast cancer.

Click the title to read the full article.

• Targeting Signaling Pathways in Inflammatory Breast Cancer
• Literature-Wide Association Studies (LWAS) for a Rare Disease: Drug Repurposing for Inflammatory Breast Cancer
• Decorin, a novel negative modulator of E-cadherin in inflammatory breast cancer
• Common cholesterol drugs could slow spread of breast cancer to brain
• Identifying Deficiencies in Inflammatory Breast Cancer Care
• FDA Approves New Therapy for Triple Negative Breast Cancer That Has Spread, Not Responded to Other Treatments
• Advancing Cancer Research and Medicine with Single-Cell Genomics
• For Metastatic HER2-Positive Breast Cancer, New Treatments Emerge
• A high neutrophil-lymphocyte ration and platelet-lymphocyte ration are associated with a worse outcome in IBC.